These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32383245)

  • 21. Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.
    Wild J; Schmiedel BJ; Maurer A; Raab S; Prokop L; Stevanović S; Dörfel D; Schneider P; Salih HR
    Leukemia; 2015 Aug; 29(8):1676-83. PubMed ID: 25710310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G; Jadidi-Niaragh F; Hojjat-Farsangi M; Asgarian-Omran H; Yousefi M; Tahmasebi F; Khoshnoodi J; Razavi SM; Saboor-Yaraghi AA; Rabbani H; Jeddi-Tehrani M; Shokri F
    Cytokine; 2013 Jun; 62(3):439-45. PubMed ID: 23579027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
    Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
    Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
    Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
    Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
    Sainz-Perez A; Gary-Gouy H; Gaudin F; Maarof G; Marfaing-Koka A; de Revel T; Dalloul A
    J Immunol; 2008 Nov; 181(9):6051-60. PubMed ID: 18941194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-expression of the functional interleukin-11 alpha receptor in the development of B-cell chronic lymphocytic leukemia.
    Tsimanis A; Shvidel L; Klepfish A; Shtalrid M; Kalinkovich A; Berrebi A
    Leuk Lymphoma; 2001 Jun; 42(1-2):195-205. PubMed ID: 11699207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia.
    Frishman J; Long B; Knospe W; Gregory S; Plate J
    J Exp Med; 1993 Apr; 177(4):955-64. PubMed ID: 8459223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
    Büssing A; Stein GM; Stumpf C; Schietzel M
    Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.
    Browning RL; Byrd WH; Gupta N; Jones J; Mo X; Hertlein E; Yu L; Muthusamy N; Byrd JC
    Cancer Immunol Res; 2016 Aug; 4(8):698-707. PubMed ID: 27287425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression.
    Rohrbacher L; Brauchle B; Ogrinc Wagner A; von Bergwelt-Baildon M; Bücklein VL; Subklewe M
    Front Immunol; 2021; 12():608625. PubMed ID: 33790890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
    Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
    PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.
    Sainz-Perez A; Gary-Gouy H; Portier A; Davi F; Merle-Beral H; Galanaud P; Dalloul A
    Leukemia; 2006 Mar; 20(3):498-504. PubMed ID: 16408101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
    Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
    Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
    Yavasoglu I; Sargin G; Kadikoylu G; Karul A; Bolaman Z
    Med Oncol; 2013; 30(3):603. PubMed ID: 23686733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.